MAbSubstitute: antibody replacement

MAbSubstitute: antibody replacement

Discovery Services

Information

MAbSubstitute; antibody substitution to find an antibody free to operate, having a sequence different from the original one, binding to same target at same epitope as original antibody (from MAbSilico antibody database, 70 million sequences). Deliverable: 5 antibody sequences binding the same epitope in 10 days
MAbSilicoMAbSilico provides a formal embedded Artificial Intelligence technology for antibody discovery, reducing the risks of failure and the duration of discovery and preclinical steps, as well as strengthening intellectual property protection. Conventional approaches for the drug discovery take up to three years, while MAbSilico technologies allow shrinking this time to a few weeks. With lead selection, characterization and optimization, MAbSilico gives you AI-based solutions using antibody sequences and delivering qualified data within 10 days.

Log in

See all the content and easy-to-use features by logging in or registering!